Immunovant Stock Performance
as on November 4, 2026 at 7:26 am IST
Day's Low
Day's High
$28.42$29.48
1.59%
Downside
2.08%
Upside
52 Week's Low
52 Week's High
$21.43$45.4225.80%
Downside
57.27%
Upside
Immunovant share price movements today
- Previous Close
- $28.41
- Open
- $28.70
- Volume
- 581.0K
- Market Cap
- $6.0B
- Day's Low - High
- $28.42 - $29.48
- 52 Week Low - High
- $21.43 - $45.42
Immunovant Historical Returns
- 1 Month Return
- -15.5 %
- 3 Month Return
- -26.23 %
- 1 Year Return
- + 19.47 %
- 3 Year Return
- -16.42 %
- 5 Year Return
- + 220.65 %
Immunovant Stock Fundamentals & Key Indicators
Check Immunovant market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$6.0B
EPS (TTM)
-2.82
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-10.34
Industry PE ratio
-7.51
PEG Ratio
-15.99
EBITDA
-538.5M
Revenue (TTM)
7.1M
Profit Margin
97.10%
Return On Equity TTM
-69.59%
Immunovant vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Immunovant with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $6.0B | 220.65% | -10.34 | 97.10% | 0.00% | |
| Neutral | $88.5B | -36.16% | -27.78 | -12.57% | 0.00% | |
| StrongBuy | $141.7B | 192.56% | 32.27 | 86.04% | 0.00% | |
| Buy | $95.5B | 47.41% | 19.76 | 85.77% | 0.40% |
Stock Returns calculator for Immunovant Stock including INR - Dollar returns
The Immunovant stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Immunovant investment value today
Current value as on today
₹1,29,682
Returns
₹29,682
(+29.68%)
Returns from Immunovant Stock
₹21,447 (+21.45%)
Dollar Impact
₹8,236 (+8.24%)
Analyst Recommendation on Immunovant Stock
Based on 9 analysts
77.78%
Buy
22.22%
Hold
0.00%
Sell
Based on 9 analysts, 77.77777777777779% of analysts recommend a 'BUY' rating for Immunovant. Average target price of $48.88
Immunovant Share Price Target
Get share price movements and forecasts by analysts on Immunovant.
What analysts predicted
40.92%UPSIDE
Target Price
$48.88
Current Price
$28.88
Analyzed by
9 Analysts
High
$66
Target
$48.88
Low
$37
Immunovant target price $48.88, a slight upside of 40.92% compared to current price of $28.88. According to 9 analysts rating.
Indian Investors' Interest in Immunovant Stock
Search interest for Immunovant Stock has increased by 19% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:19% versus previous 30 day period
Immunovant Quarterly Profit & Loss
All numbers in Millions USD
Immunovant Annual Profit & Loss
All numbers in Millions USD
Immunovant Quarterly Cash Flow
All numbers in Millions USD
Immunovant Annual Cash Flow
All numbers in Millions USD
Immunovant News & Key Events
Insights on Immunovant
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 3 years, Moderna, Inc. Common Stock has given 184.8% return, outperforming this stock by 201.2%
- NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 786.5% return, outperforming this stock by 767.0%
NEGATIVE IMPACTPrice Dip
In the last 1 month, IMVT stock has moved down by -15.5%
About Immunovant
| Organisation | Immunovant |
| Headquarters | 1000 Park Forty Plaza, Durham, NY, 27713, US |
| Industry | Biotechnology |
| CEO | Eric Venker |
Key Management of Immunovant
Name | Title |
|---|---|
Ms. Christine Blodgett | Senior Vice President of Human Resources |
Ms. Yan Zheng M.S., Ph.D. | Senior Vice President of Biostatistics, Programming & Data Management |
Ms. Sheetal Patel M.B.A., M.D., M.S. | Senior Vice President of Clinical Development |
Dr. Frank M. Torti M.B.A., M.D. | Executive Chairperson of the Board |
Dr. Eric Venker M.D., Pharm.D. | CEO & Director |
Dr. Jay S. Stout M.S., Ph.D. | Chief Technology Officer |
Ms. Becky Merlina | Senior VP & Global Head of Quality |
Mr. Tiago M. Girao CPA | Chief Financial Officer |
Ms. Melanie Gloria B.S.N. | Chief Operating Officer |
Mr. Christopher A. Van Tuyl Esq., J.D. | Chief Legal Officer & Corporate Secretary |
FAQs
What is Immunovant share price today?
Immunovant share price today is $28.88 as on . Immunovant share today touched a day high of $29.48 and a low of $28.42.
What is the 52 week high and 52 week low for Immunovant share?
Immunovant share touched a 52 week high of $45.42 on and a 52 week low of $21.43 on . Immunovant stock price today i.e. is trending at $28.88,which is 36.42% down from its 52 week high and 34.76% up from its 52 week low.
What is Immunovant's market capitalisation today?
Immunovant market capitalisation is $0.01T as on .
How to invest in Immunovant Stock (IMVT) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Immunovant on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Immunovant Stock (IMVT) from India?
Indian investors can start investing in Immunovant (IMVT) shares with as little as ₹94.73999786376953 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹947.40 in Immunovant stock (as per the Rupee-Dollar exchange rate as on ).
Based on Immunovant share’s latest price of $28.88 as on November 4, 2026 at 1:56 am IST, you will get 0.3463 shares of Immunovant. Learn more about
fractional shares .
What are the returns that Immunovant has given to Indian investors in the last 5 years?
Immunovant stock has given 220.65% share price returns and 27.47% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?